SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001493152-23-024106
Filing Date
2023-07-10
Accepted
2023-07-10 15:47:41
Documents
13
Period of Report
2023-07-10
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-ka.htm   iXBRL 8-K/A 45286
2 ex10-1.htm EX-10.1 15122
  Complete submission text file 0001493152-23-024106.txt   233830

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE bstg-20230710.xsd EX-101.SCH 3015
4 XBRL LABEL FILE bstg-20230710_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE bstg-20230710_pre.xml EX-101.PRE 22359
7 EXTRACTED XBRL INSTANCE DOCUMENT form8-ka_htm.xml XML 3130
Mailing Address 84 OCTOBER HILL ROAD SUITE 11 HOLLISTON MA 01746
Business Address 84 OCTOBER HILL ROAD SUITE 11 HOLLISTON MA 01746 (774) 233-7300
Biostage, Inc. (Filer) CIK: 0001563665 (see all company filings)

IRS No.: 455210462 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-35853 | Film No.: 231079697
SIC: 3841 Surgical & Medical Instruments & Apparatus